Influence of botulinum toxin on rabbit jaw muscle activity and anatomy

Muscle and Nerve

Volumn 45, Issue 5, 2012, Pages 684-691

  Korfage, J A M ^a   Wang, Jeffrey ^a   Lie, S H J T J ^a   Langenbach, Geerling E J ^a  

^a VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

Adaptation; Botulinum toxin; Digastric; Mastication muscles; Rabbit; Temporalis

Indexed keywords

BOTULINUM TOXIN A;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOCHEMICAL COMPOSITION; CONTROLLED STUDY; ELECTRODE; ELECTROMYOGRAPHY; EXPERIMENTAL STUDY; IMMUNOHISTOCHEMISTRY; INJECTION; JAW MUSCLE; MALE; MASSETER MUSCLE; MICROSCOPY; MUSCLE CELL; MUSCLE CONTRACTION; MUSCLE POTENTIAL; NONHUMAN; PRIORITY JOURNAL; RABBIT; TEMPORALIS MUSCLE;

ANIMALS; BOTULINUM TOXINS, TYPE A; ELECTRIC STIMULATION; ELECTROMYOGRAPHY; FUNCTIONAL LATERALITY; MALE; MASSETER MUSCLE; NEUROMUSCULAR AGENTS; RABBITS; STATISTICS, NONPARAMETRIC; TIME FACTORS;

EID: 84859771535     PISSN: 0148639X     EISSN: 10974598     Source Type: Journal    
DOI: 10.1002/mus.23229     Document Type: Article

References (50)

1. Bottinelli R, Caneparri M, Pellegrino MA, Reggiani C. Force-velocity properties of human skeletal muscle fibers: myosin heavy chain isoforms and temperature dependence. J Physiol 1996; 495: 573-586.
2. Monster AW, Chan H, O'Connor D. Activity patterns of human skeletal muscles: relation to muscle fiber type composition. Science 1978; 200: 314-317.
3. Kernell D, Hensbergen E. Use and fiber type composition in limb muscles of cats. Eur J Morphol 1998; 36: 288-292.
4. Kernell D, Hensbergen E, Lind A, Eerbeek O. Relation between fiber composition and daily duration of spontaneous activity in ankle muscles of the cat. Arch Ital Biol 1998; 136: 191-203.
5. van Wessel T, Langenbach GEJ, Korfage JAM, Brugman P, Kawai N, Tanaka E, et al. Fiber-type composition of rabbit jaw muscles is related to their daily activity. Eur J Neurosci 2005; 22: 2783-2791.
6. Edgerton VR, Zhou M-Y, Ohira Y, Klitgaard H, Jiang B, Bell G, et al. Human fiber size and enzymatic properties after 5 and 11 days of spaceflight. J Appl Physiol 1995; 78: 1733-1739.
7. Guarda-Nardini L, Manfredi D, Salamone M, Salmaso L, Tonello S, Ferronato G. Efficacy of botulinum toxin in treating myofascial pain in bruxers: a controlled placebo pilot study. Cranio 2008; 26: 126-135.
8. Lee SJ, McCall WD Jr, Kim YK, Chung SC, Chung JW. Effect of botulinum toxin injection on nocturnal bruxism: a randomized controlled trial. Am J Phys Med Rehabil 2010; 89: 16-23.
9. Al-Muharraqi MA, Fedorowicz Z, Al Bareeq J, Al Bareeq R, Nasser M. Botulinum toxin for masseter hypertrophy. Cochrane Database Syst Rev 2009; 1: CD007510.
10. Laskawi R. The use of botulinum toxin in head and face medicine: an interdisciplinary field. Head Face Med 2008; 4: 5.
11. Maestre-Ferrin L, Burguera JA, Peñarrocha-Diago M, Peñarrocha-Diago M. Oromandibular dystonia: a dental approach. Med Oral Patol Cir Bucal 2010; 15: e25-28.
12. CotéTR, Mohan AK, Polder JA, Walton MK, Braun MM. Botulinum toxin type A injections: adverse events reported to the US Food and Drug Administration in therapeutic and cosmetic cases. J Am Acad Dermatol 2005; 53: 407-415.
13. Crowner BE, Torres-Russotto D, Carter AR, Racette BA. Systemic weakness after therapeutic injections of botulinum toxin A: a case series and review of the literature. Clin Neuropharmacol 2010; 33: 243-247.
14. Black JD, Dolly JO. Selective location of acceptors for botulinum neurotoxin A in the central and peripheral nervous systems. Neuroscience 1987; 23: 767-779.
15. Dolly JO, Aoki KR. The structure and mode of action of different botulinum toxins. Eur J Neurol 2006; 13( suppl 4): 1-9.
16. Jankovic J, Brin MF. Therapeutic uses of botulinum toxin. N Engl J Med 1991; 25: 1186-1194.
17. Dodd SL, Selsby J, Payne A, Judge A, Dott C. Botulinum neurotoxin type A causes shifts in myosin heavy chain composition in muscle. Toxicon 2005; 46: 196-203.
18. Legerlotz K, Matthews KG, McMahon CD, Smith HK. Botulinum toxin-induced paralysis leads to slower myosin heavy chain isoform composition and reduced titin content in juvenile rat gastrocnemius muscle. Muscle Nerve 2009; 39: 472-479.
19. Kranjc BS, Sketelj J, D'Albis A, Eržen I. Long-term changes in myosin heavy chain composition after botulinum toxin A injection into rat medial rectus muscle. Invest Ophtalmol Vis Sci 2001; 42: 3158-3164.
20. Ugalde I, Chrisgtiansen SP, McLoon LK. Botulinum toxin treatment of extraocular muscles in rabbits results in increased myofiber remodelling. Invest Ophthalmol Vis Sci 2005; 25: 4114-4120.
21. Inage K, Connor NP, Schultz E, Ford CN, Cook CH, Heisey DM. Muscle fiber-type changes induced by botulinum toxin injection in the rat larynx. Otolaryngol Head Neck Surg 1999; 120: 876-883.
22. Nuijens FW, Snelderwaard PC, Bout RG. An electromyographic technique for small animals. J Neurosci Methods 1997; 76: 71-73.
23. van Wessel T, Langenbach GEJ, Brugman P, van Eijden TMGJ. Long-term registration of daily jaw muscle activity in juvenile rabbits. Exp Brain Res 2005; 162: 315-323.
24. Langenbach GEJ, van Ruijven LJ, van Eijden TMGJ. A telemetry system to chronically record muscle activity in middle-sized animals. J Neurosci Methods 2002; 114: 197-203.
25. van Wessel T, Langenbach GEJ, Kawai N, Brugman P, Tanaka E, van Eijden TMGJ. Burst characteristics of daily jaw muscle activity in juvenile rabbits. J Exp Biol 2005; 208: 2539-2547.
26. Wessels A, Vermeulen JLM, Moorman AFM, Becker AE. Immunohistochemical detection of myosin heavy chain isoforms in large sections of whole human hearts. In: Sarcomeric and non-sarcomeric muscles: basic and applied research prospects for the 90's. Padova: Unipress; 1988. p 311-316.
27. Bredman JJ, Wessels A, Weijs WA, Korfage JA, Soffers CA, Moorman AF. Demonstration of 'cardiac-specific' myosin heavy chain in masticatory muscles of human and rabbit. Histochem J 1991; 23: 160-170.
28. Sant'Ana Pereira JAA, Wessels A, Nijtmans L, Moorman AFM, Sargeant AJ. New method for the accurate characterization of single human skeletal muscle fibers demonstrates a relation between mATPase and MyHC expression in pure and hybrid fiber types. J Muscle Res Cell Motil 1995; 16: 21-34.
29. Wessels A, Vermeulen JLM, Viragh S, Kálmán F, Lamers WH, Moorman AFM. Spatial distribution of "tissue specific" antigens in the developing human heart and skeletal muscle. II. An immunohistochemical analysis of myosin heavy chain isoform expression patterns in the embryonic heart. Anat Rec 1991; 229: 355-368.
30. Sant'Ana Pereira JAA, Moorman AFM. Do type IIB fibers of human muscle correspond to the IIX/D or to the IIB of rats? J Physiol 1994; 479P: 161P-162P.
31. Hancock MB. A serotonin-immunoreactive fiber system in the dorsal columns of the spinal cord. Neurosci Lett 1982; 31: 247-252.
32. Korfage JAM, van Eijden TMGJ. Myosin isoform composition of the human medial and lateral pterygoid muscles. J Dent Res 2000; 79: 1618-1625.
33. Korfage JAM., Helmers R, de Goüyon Matignon M, van Wessel T, Langenbach GEJ, van Eijden TMGJ. Postnatal development of fiber type composition in rabbit jaw and leg muscles. Cells Tissue Org 2009; 190: 42-52.
34. Kim KS, Byun YS, Kim YJ, Kim ST. Muscle weakness after repeated injection of botulinum toxin type A evaluated according to bite force measurement of human masseter muscle. Dermatol Surg 2009; 35: 1902-1906.
35. Kim C, McCall WD, Kim YK, Chung JW. Effect of botulinum toxin on pressure pain threshold and EMG power spectrum of masseter muscle during sustained fatiguing contraction. Am J Phys Med Rehabil 2010; 89: 736-743.
36. Dulor JP, Cambon B, Vigneron P, Reyne Y, Nouguès J, Casteilla L, et al. Expression of specific white adipose tissue genes in denervated-induced skeletal muscle fatty degeneration. FEBS Lett 1998; 439: 89-92.
37. Rosales RL, Arimura K, Takenaga S, Osame M. Extrafusal and intrafusal muscle effects in experimental botulinum toxin-A injections. Muscle Nerve 1996; 19: 488-496.
38. Choe SW, Cho WI, Lee CK, Seo SJ. Effects of botulinum toxin type A on contouring of the lower face. Dermatol Surg 2005; 31: 502-508.
39. Bhidayasiri R, Cardoso F, Truong DD. Botulinum toxin in blepharospasm and oromandibular dystonia: comparing different botulinum toxin preparations. Eur J Neurol 2006; 13: 21-29.
40. Blanksma NG, van Eijden TMGJ, van Ruijven LJ, Weijs WA. Electromyographic heterogeneity in the human temporalis and masseter muscles during dynamic tasks guided by visual feedback. J Dent Res 1997; 76: 542-551.
41. Filippi GM, Errico P, Santarelli R, Bagolini B, Manni E. Botulinum A toxin effects on rat jaw muscle spindles. Acta Otolaryngol 1993; 113: 400-404.
42. De Paiva A, Meunier FA, Molgó J, Aoki KR, Dolly JO. Functional repair of motor endplates after botulinum neurotoxin type A poisoning: biphasic switch of synaptic activity between nerve sprouts and their parent terminals. Proc Natl Acad Sci 1999; 96: 3200-3205.
43. Ahn KY, Kim ST. The change of maximum bite force after botulinum toxin type A injection for treating masseteric hypertrophy. Plast Reconstr Surg 2007; 120: 1662-1666.
44. Kim J-H, Shin JH, Kim ST, Kim S-Y. Effects of two different units of botulinum toxin type A evaluated by computed tomography and electromyographic measurements of human masseter muscle. Plast Reconstr Surg 2007; 119: 711-717.
45. Korfage JAM, Schueler YT, Brugman P, van Eijden TMGJ. Differences in myosin heavy-chain composition between human jaw-closing muscles and supra- and infrahyoid muscles. Arch Oral Biol 2001; 46: 821-827.
46. Yaraskavitch M, Leonard T, Herzog W. BoNT-A produces functional weakness in non-injected muscles adjacent to the target muscle. J Biomech 2008; 41: 897-902.
47. Fortuna R, Vaz MA, Youssef AR, Longino D, Herzog W. Changes in contractile properties of muscles receiving repeat injections of botulinum toxin (Botox). J Biomech 2011; 44: 39-44.
48. Borodic GE, Ferrante R, Pearce LB, Smith K. Histologic assessment of dose-related diffusion and muscle fiber response after therapeutic botulinum A toxin injections. Mov Disord 1994; 9: 31-39.
49. Noden DM, Francis-West P. The differentiation and morphogenesis of craniofacial muscles. Dev Dyn 2006; 235: 1194-1218.
50. Pavlath GK, Thaloor D, Rando TA, Cheong M, English AW, Zheng B. Heterogeneity among muscle precursor cells in adult skeletal muscles with differing regenerative capacities. Dev Dyn 1998; 212: 495-508.